Prediction and Prevention: Seeking the Holy Grail of Childhood Cancer Predisposition
Objectives and Disclosures
Participants will be able to:
- Evaluate the impact of early tumor detection strategies on outcomes of children with cancer predisposition syndromes.
- Employ conventional history and physical examination skills to identify and manage children at genetic risk of cancer.
- Formulate a strategy to integrate germline and somatic molecular findings in pediatric cancer patients into short- and long-term clinical management.
Planners and speaker disclose they have no relevant financial relationships.
David Malkin, MD, FRCPC
Professor, Pediatrics and Medical Biophysics, University of Toronto; CIBC Children’s Foundation Chair, Child Health Research, Oncologist, Division of Hematology/Oncology, Director of the Cancer Genetics program, and Senior Scientist, Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto
Seattle Children’s is accredited by the Washington State Medical Association CME Accreditation Committee to sponsor continuing medical education for physicians.
Seattle Children’s designates this online educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 1 hour of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
Videos are available for only one year after posting.
If you wish to receive Category I CME credit for viewing this Provider Grand Rounds session, please complete the evaluation form. Upon completion of the form you will receive an auto-reply email that will serve as the only confirmation of your CME credit. Please keep the email for your records.